Stock Events

Regenicin 

$0
5
-$0-99% Monday 19:07

Statistics

Day High
0
Day Low
0
52W High
0.01
52W Low
0
Volume
900,000
Avg. Volume
1,825
Mkt Cap
76,885
P/E Ratio
0
Dividend Yield
-
Dividend
-

Earnings

12AugConfirmed
Q2 2020
Q4 2020
Q1 2021
Q2 2021
Q4 2021
Q1 2022
Q2 2022
-0
-0
-0
0
Expected EPS
N/A
Actual EPS
-0.0012

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RGIN. It's not an investment recommendation.

About

Miscellaneous Commercial Services
Manufacturing
Biotechnology
Health Technology
Commercial Services
Industrial and Commercial Fan and Blower and Air Purification Equipment Manufacturing
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. The company's product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. Its products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.
Show more...
CEO
Employees
3
Country
US
ISIN
US75887Q1022

Listings